In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.

Source:http://linkedlifedata.com/resource/pubmed/id/20228222

Download in:

View as

Triples

General Info

PMID
20228222